© 2024 © 2020 Genprex Inc. All Rights Reserved.
Reqorsa® Immunogene Therapy May be a Potential Therapy for ALK-Positive Lung Cancer
Acclaim-1 Phase 1 study had no Dose Limiting Toxicity, and results establish Phase 2 Recommended Dose as well as provide data showing efficacy of REQORSA® in combination with Tagrisso®